Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
VanEck Agribusiness ETF
MOO
$968M
| $284K | ﹤0.01% |
3,310
| – | – |
|
3552
Acco Brands
ACCO
$399M
| $284K | ﹤0.01% |
50,819
+19,772
| +64% | +$103K |
|
3553
Stantec
STN
$8.17B
| $283K | ﹤0.01% |
5,900
+3,300
| +127% | +$159K |
|
3554
Conduent
CNDT
$268M
| $283K | ﹤0.01% |
69,834
+51,238
| +276% | +$196K |
|
3555
Global X Lithium & Battery Tech ETF
LIT
$1.5B
| $282K | ﹤0.01% |
4,819
+659
| +16% | +$44K |
|
3556
iShares MSCI Singapore ETF
EWS
$1.05B
| $281K | ﹤0.01% |
14,942
-8,018
| -35% | -$145K |
|
3557
Dyne Therapeutics
DYN
$4.71B
| $281K | ﹤0.01% |
24,243
+7,164
| +42% | +$82.9K |
|
|
ORLA
3558
DELISTED
Orla Mining
ORLA
| $281K | ﹤0.01% |
69,500
+7,900
| +13% | +$28.3K |
|
3559
Koppers
KOP
$976M
| $281K | ﹤0.01% |
9,950
+1,271
| +15% | +$34.3K |
|
3560
Utz Brands
UTZ
$1.25B
| $280K | ﹤0.01% |
17,648
+14,642
| +487% | +$243K |
|
3561
Aurinia Pharmaceuticals
AUPH
$1.87B
| $280K | ﹤0.01% |
64,723
-592,079
| -90% | -$3.44M |
|
3562
CVR Energy
CVI
$3.31B
| $278K | ﹤0.01% |
8,856
-7,404
| -46% | -$263K |
|
3563
OraSure Technologies
OSUR
$286M
| $277K | ﹤0.01% |
57,556
+29,989
| +109% | +$137K |
|
3564
German American Bancorp
GABC
$1.92B
| $277K | ﹤0.01% |
7,435
+6,189
| +497% | +$236K |
|
|
CTO
3565
CTO Realty Growth
CTO
$827M
| $276K | ﹤0.01% |
15,104
+4,718
| +45% | +$90.6K |
|
3566
CALL
Marqeta
MQ
$1.88B
| $275K | ﹤0.01% |
+11,250
| New | +$307K |
|
3567
Repay Holdings
RPAY
$343M
| $273K | ﹤0.01% |
33,907
+7,496
| +28% | +$53.9K |
|
|
TWOU
3568
DELISTED
2U Inc
TWOU
| $273K | ﹤0.01% |
1,450
+321
| +28% | +$63.7K |
|
3569
Joby Aviation
JOBY
$7.26B
| $272K | ﹤0.01% |
81,278
+58,538
| +257% | +$237K |
|
|
SNBR
3570
DELISTED
Sleep Number
SNBR
| $272K | ﹤0.01% |
10,460
+4,391
| +72% | +$133K |
|
|
UBA
3571
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $271K | ﹤0.01% |
14,324
-29,675
| -67% | -$542K |
|
3572
Credit Acceptance
CACC
$5.99B
| $271K | ﹤0.01% |
572
-3,602
| -86% | -$1.65M |
|
|
MACA
3573
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
| $271K | ﹤0.01% |
26,871
-52,721
| -66% | -$527K |
|
3574
Brookfield Asset Management
BAM
$80.9B
| $271K | ﹤0.01% |
+9,435
| New | +$284K |
|
3575
Silvercrest Asset Management
SAMG
$80.4M
| $270K | ﹤0.01% |
14,378
+2,176
| +18% | +$39.2K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.